Rick Wise
Stock Analyst at Stifel
(4.12)
# 477
Out of 5,147 analysts
267
Total ratings
60.83%
Success rate
9.57%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $98 | $84.27 | +16.29% | 4 | Feb 5, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $125 → $110 | $76.85 | +43.14% | 18 | Feb 5, 2026 | |
| JNJ Johnson & Johnson | Maintains: Hold | $205 → $220 | $248.43 | -11.44% | 8 | Jan 22, 2026 | |
| EW Edwards Lifesciences | Maintains: Buy | $105 → $110 | $86.47 | +27.21% | 29 | Jan 20, 2026 | |
| MDLN Medline | Initiates: Buy | $46 | $47.51 | -3.18% | 1 | Jan 12, 2026 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $5 → $3 | $1.86 | +61.29% | 10 | Jan 7, 2026 | |
| SOLV Solventum | Maintains: Buy | $88 → $105 | $74.20 | +41.51% | 2 | Jan 7, 2026 | |
| OM Outset Medical | Maintains: Buy | $14 → $8 | $3.49 | +129.23% | 6 | Jan 7, 2026 | |
| LIVN LivaNova | Maintains: Buy | $65 → $70 | $70.60 | -0.85% | 7 | Jan 7, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $210 → $215 | $176.48 | +21.83% | 9 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $23.16 | +72.71% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $19.17 | +4.33% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $105 | $97.66 | +7.52% | 12 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $46 | $38.50 | +19.48% | 8 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $118 | $98.44 | +19.87% | 16 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $36 → $25 | $20.37 | +22.73% | 9 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $5 | $1.58 | +216.46% | 5 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $55 | $46.00 | +19.57% | 12 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $116.35 | +24.62% | 21 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $23.28 | +20.27% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $48 | $31.26 | +53.55% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $387.46 | +13.56% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $503.51 | +21.15% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $175.35 | +8.35% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $7.61 | +57.69% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $108.18 | -30.67% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $25.30 | -5.14% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $14.10 | +77.30% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $49.94 | +124.27% | 5 | Oct 2, 2020 |
GE HealthCare Technologies
Feb 5, 2026
Maintains: Buy
Price Target: $95 → $98
Current: $84.27
Upside: +16.29%
Boston Scientific
Feb 5, 2026
Maintains: Buy
Price Target: $125 → $110
Current: $76.85
Upside: +43.14%
Johnson & Johnson
Jan 22, 2026
Maintains: Hold
Price Target: $205 → $220
Current: $248.43
Upside: -11.44%
Edwards Lifesciences
Jan 20, 2026
Maintains: Buy
Price Target: $105 → $110
Current: $86.47
Upside: +27.21%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $46
Current: $47.51
Upside: -3.18%
Treace Medical Concepts
Jan 7, 2026
Maintains: Hold
Price Target: $5 → $3
Current: $1.86
Upside: +61.29%
Solventum
Jan 7, 2026
Maintains: Buy
Price Target: $88 → $105
Current: $74.20
Upside: +41.51%
Outset Medical
Jan 7, 2026
Maintains: Buy
Price Target: $14 → $8
Current: $3.49
Upside: +129.23%
LivaNova
Jan 7, 2026
Maintains: Buy
Price Target: $65 → $70
Current: $70.60
Upside: -0.85%
Becton, Dickinson and Company
Jan 7, 2026
Maintains: Buy
Price Target: $210 → $215
Current: $176.48
Upside: +21.83%
Nov 13, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $23.16
Upside: +72.71%
Oct 10, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $19.17
Upside: +4.33%
Oct 9, 2025
Maintains: Hold
Price Target: $90 → $105
Current: $97.66
Upside: +7.52%
Sep 29, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $38.50
Upside: +19.48%
Sep 19, 2025
Maintains: Buy
Price Target: $115 → $118
Current: $98.44
Upside: +19.87%
Aug 4, 2025
Downgrades: Hold
Price Target: $36 → $25
Current: $20.37
Upside: +22.73%
Jul 31, 2025
Maintains: Buy
Price Target: $16 → $5
Current: $1.58
Upside: +216.46%
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $46.00
Upside: +19.57%
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $116.35
Upside: +24.62%
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $23.28
Upside: +20.27%
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $31.26
Upside: +53.55%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $387.46
Upside: +13.56%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $503.51
Upside: +21.15%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $175.35
Upside: +8.35%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $7.61
Upside: +57.69%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $108.18
Upside: -30.67%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $25.30
Upside: -5.14%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $14.10
Upside: +77.30%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $49.94
Upside: +124.27%